CC
OFIX icon

Clearline Capital’s Orthofix Medical OFIX Stock Holding History

Clearline Capital’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-117,891
Closed -$1.84M – 138
2024
Q3 		$1.84M Sell
117,891
-131,537
-53% -$2.11M 0.08% 101
2024
Q2 		$3.31M Sell
249,428
-9,766
-4% -$134K 0.09% 79
2024
Q1 		$3.76M Sell
259,194
-61,928
-19% -$856K 0.18% 62
2023
Q4 		$4.33M Sell
321,122
-200,624
-38% -$2.36M 0.27% 55
2023
Q3 		$6.71M Buy
+521,746
New +$9.39M 0.58% 49

Other funds holding OFIX

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
ECM
Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
BCM
Boone Capital Management Atlanta, Georgia $428M AUM 136.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Clearline Capital's OFIX Position: Q4 2024 in Review

Clearline Capital sold out of Orthofix Medical (OFIX) in Q4 2024, closing a stake of 117,891 shares — an estimated $1.84M sold.

Clearline Capital first reported a position in OFIX in Q3 2023 and held it in 5 quarters. The position peaked at $6.71M in Q3 2023. 149 funds tracked by Wall St. Rank hold OFIX as of Q4 2024.

  • Clearline Capital reported no remaining Orthofix Medical position as of Q4 2024 after selling out during the quarter.
  • Clearline Capital sold 117,891 Orthofix Medical shares in Q4 2024, an estimated $1.84M.
  • Clearline Capital first reported a position in Orthofix Medical in Q3 2023 and held it in 5 quarters.
  • Clearline Capital's Orthofix Medical position peaked at $6.71M in Q3 2023.
  • 149 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2024.

Based on Clearline Capital's 13F filing for Q4 2024, filed 14 Feb 2025.